Abstract
Acute kidney injury and fluid overload are common in critically ill patients and both associated with increased mortality. Furosemide has several pharmacological properties that could theoretically protect the kidneys against ischaemic injury by decreasing oxygen consumption. Furosemide might also counteract the harmful effects of fluid overload by promoting diuresis and achieving negative fluid balance. Few randomised trials have compared furosemide administration as either bolus doses or continuous infusion, and in most of them surrogate outcomes have been used. No differences in mortality were observed in two studies, whereas another study found a lower mortality with continuous infusion. A meta-analysis focusing on continuous infusion versus bolus administration of furosemide found no difference in mortality between the two regimens. In conclusion, there is only weak evidence to support that furosemide by continuous infusion may provide advantages as compared with bolus doses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vaara ST, Korhonen AM, Kaukonen KM et al (2012) Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI-study. Crit Care 16:R197
Bouchard J, Soroko SB, Chertow GM et al (2009) Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76(4):422–427
de Oliveira FS, Freitas FG, Ferreira EM et al (2015) Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. J Crit Care 30(1):97–101
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2(1):1–138
Copeland JG, Campbel DW, Plachetka JR et al (1983) Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg 146(6):796–799
Schuller D, Lynch JP, Fine D (1997) Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med 25(12):1969–1975
Martin GS, Mangialardi RJ, Wheeler AP et al (2002) Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 30(10):2175–2182
Mojtahedzadeh M, Salehifar E, Vazin A et al (2004) Comparison of hemodynamic and biochemical effects of furosemide by continuous infusion and intermittent bolus in critically ill patients. J Infus Nurs 27(4):255–261
Ostermann M, Alvarez G, Sharpe MD, Martin CM (2007) Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract 107(2):c70–c76
Kunt AT, Akgun S, Atalan N et al (2009) Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery. Anadolu Kardiyol Derg 9(6):499–504
Landoni G, Bove T, Szekely A et al (2013) Reducing mortality in acute kidney injury patients: systematic review and international web-based survey. J Cardiothorac Vasc Anesth 27(6):1384–1398
Zangrillo A, Cabrini L, Monti G et al (2011) Continuous infusion versus bolus injection of furosemide in critically ill patients: a systematic review and meta-analysis. Signa Vitae 6:58–63
Ponto LL, Schoenwald RD (1990) Furosemide (frusemide) a pharmacokinetic/pharmacodynamic review (part I). Clin Pharmacokinet 18:381–408
Ponto LL, Schoenwald RD (1990) Furosemide (frusemide) a pharmacokinetic/pharmacodynamic review (part II). Clin Pharmacokinet 18:460–471
Ludens JH, Williamson HE (1970) Effect of furosemide on renal blood flow in the conscious dog. Proc Soc Exp Biol Med 133:513–515
Ho KM, Sheridan DJ (2006) Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 333(7565):420
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ibsen, M., Perner, A. (2016). Furosemide by Continuous Infusion to Reduce Mortality in Patients with Acute Kidney Injury. In: Landoni, G., Pisano, A., Zangrillo, A., Bellomo, R. (eds) Reducing Mortality in Acute Kidney Injury. Springer, Cham. https://doi.org/10.1007/978-3-319-33429-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-33429-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33427-1
Online ISBN: 978-3-319-33429-5
eBook Packages: MedicineMedicine (R0)